Slides on Contemporary Management of Behçet’s Disease: Merging Multidisciplinary Approaches With Emerging Therapies

Review slides on key considerations for the diagnosis and treatment of Behcet’s disease, including patient demographics, genetic associations, historical and emerging treatment options.
Yusuf Yazici, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 487 KB
Released: November 18, 2019

Acknowledgements

Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by an educational grant from
Celgene

Related Content

CCO faculty Dr Kenneth Calamia discusses the clinical features of Behçet’s disease and how to weigh symptoms when making a diagnosis

Kenneth T. Calamia, MD Released: January 28, 2020

CCO faculty Dr. Yusuf Yazici on treating mucocutaneous manifestations such as oral ulcers in Behçet’s: apremilast, colchicine, dapsone, pentoxifylline, thalidomide

Yusuf Yazici, MD Released: December 16, 2019

Text-based module featuring expert commentary from Yusuf Yazici, MD, on key considerations for diagnosis and treatment of Behcet’s disease

Yusuf Yazici, MD Physicians: maximum of 0.6 AMA PRA Category 1 Credits Released: November 18, 2019 Expired: November 17, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue